EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Application of a bioengineered intestinal epithelium for drug permeability and metabolism studies

Elisabeth Gill, Stephanie Muenchau Schoepp iD, Sina Simon, Marius F Harter, Mikhail Nikolaev, Iago Pereiro iD, Inês Silva, Rubén López-Sandoval iD, Marco Berrera iD, Tony Kam-Thong, Marco Michalski, Michael Zaayman und 9 weitere

Lab on a Chip · 2025

DOI: 10.1039/d5lc00626k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lab on a Chip, 2025. Verfasst von Elisabeth Gill und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. nikolche.gjorevski@…. Hauptthemen laut MEDLINE: Bioengineering, Intestinal Mucosa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gill, Muenchau et al. demonstrated the presence of key drug transporters and metabolic enzymes in an engineered intestinal barrier model, and combined the system with in silico modeling to simultaneously capture drug permeability and metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioengineeringIntestinal MucosaHumansOrganoidsIntestinal Barrier FunctionEpithelium

Autor:innen und Institutionen

  • Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. nikolche.gjorevski@roche.com.
  • Pharmaceutical Sciences, Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland. nicolo.milani@roche.com.
  • Roche Pharmaceutical Research and Development, Synthetic Molecules Technical Development, Basel, Switzerland.
  • Gustave Roussy Cancer Campus, University Paris-Saclay, Paris, France.
  • Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
  • Data & Analytics, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

ORCID-Profile: Stephanie Muenchau Schoepp, Iago Pereiro, Rubén López-Sandoval, Marco Berrera, Michael Hofmann, Stephen Fowler, Nikolche Gjorevski

Zitieren

APA

Gill, E., Muenchau Schoepp, S., Simon, S., Harter, M. F., Nikolaev, M., Pereiro, I., Silva, I., López-Sandoval, R., Berrera, M., Kam-Thong, T., Michalski, M., Zaayman, M., Aubert, J., Cubela, I., Keemink, J., Stillhart, C., Hofmann, M., Fowler, S., Camp, J. G., …, & Gjorevski, N. (2025). Application of a bioengineered intestinal epithelium for drug permeability and metabolism studies. Lab on a Chip. https://doi.org/10.1039/d5lc00626k

Vancouver

Gill E, Muenchau Schoepp S, Simon S, Harter MF, Nikolaev M, Pereiro I, et al. Application of a bioengineered intestinal epithelium for drug permeability and metabolism studies. Lab on a Chip. 2025. doi:10.1039/d5lc00626k

BibTeX
@article{Gill2025,
  author = {Gill, Elisabeth and Muenchau Schoepp, Stephanie and Simon, Sina and Harter, Marius F and Nikolaev, Mikhail and Pereiro, Iago and Silva, Inês and López-Sandoval, Rubén and Berrera, Marco and Kam-Thong, Tony and Michalski, Marco and Zaayman, Michael and Aubert, Julien and Cubela, Irineja and Keemink, Janneke and Stillhart, Cordula and Hofmann, Michael and Fowler, Stephen and Camp, J Gray and Milani, Nicolo and Gjorevski, Nikolche},
  title = {Application of a bioengineered intestinal epithelium for drug permeability and metabolism studies},
  journal = {Lab on a Chip},
  year = {2025},
  doi = {10.1039/d5lc00626k}
}
Kostenlos starten →